Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1069 OX40/CD137 dual agonism potentiates anti-tumour immunity by driving functional reprogramming and instability of regulatory T (Treg) cells
Compose a Response to This Article
Other responses
No responses have been published for this article.